These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 4965532)

  • 1. [Determination of the ABO Rhesus blood group of the fetus in utero by examination of the epithelial cells of the amniotic fluid by immunofluorescence].
    Seigneurin R; Reboud P; Magnis R; Goullier A
    Ann Biol Clin (Paris); 1967; 25(7):913-7. PubMed ID: 4965532
    [No Abstract]   [Full Text] [Related]  

  • 2. Fetal blood group determination in amniotic cells.
    Vázquez-Escobosa C; Pérez-Medina R; Ramos-Damián ME; Gómez-Estrada H
    Arch Invest Med (Mex); 1982; 13(2):101-4 passim. PubMed ID: 6808946
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prenatal determination of the fetal blood group].
    Meroni P; Della Torre L
    Ann Ostet Ginecol Med Perinat; 1969 Jul; 91(7):497-507. PubMed ID: 4997558
    [No Abstract]   [Full Text] [Related]  

  • 4. [Demonstration by immunofluorescence of anti-Rhesus antibodies fixed on amniotic cells from mothers immunized with Rhesus factor].
    Ducos J; Ruffié J; Ohayon E; Marty Y
    C R Seances Soc Biol Fil; 1966; 160(12):2484-6. PubMed ID: 4228405
    [No Abstract]   [Full Text] [Related]  

  • 5. [Haemolytic disease of the newborn (fetus) (author's transl)].
    Fischer K; Poschmann A
    Immun Infekt; 1976 Dec; 4(6):249-60. PubMed ID: 828142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention and anticipation of Rhesus isoimmunization].
    Ravina JH; Poulain M; Lepage F
    Presse Med (1893); 1969 Oct; 77(43):1511-3. PubMed ID: 4187490
    [No Abstract]   [Full Text] [Related]  

  • 7. [Various experiences with amniotic fluid studies in relation to the prognosis of the severity of hemolytic disease of the newborn].
    Seelen JC; van Kessel HI
    Ned Tijdschr Verloskd Gynaecol; 1968 Feb; 68(1):47-55. PubMed ID: 4968223
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of Rh sensitization by means of anti D application].
    Schneider J
    Bibl Haematol; 1969; 32():113-23. PubMed ID: 4980798
    [No Abstract]   [Full Text] [Related]  

  • 9. [Letter: Fetal blood group and rhesus determination in utero].
    Mention JE; Genetet N; Fauchet R; de Villartay A
    Nouv Presse Med; 1975 Sep; 4(31):2269. PubMed ID: 809753
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prediction of fetal blood group from amniotic fluid and use in hemolytic disease of the newborn (author's transl)].
    Qian ML
    Zhonghua Fu Chan Ke Za Zhi; 1982 Jan; 17(1):21-3. PubMed ID: 6807636
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of the amniotic fluid and particularly amniotic bilirubin in various cases of pathologic pregnancy].
    Pigeaud H; Béthoux R
    Rev Lyon Med; 1968 Jan; 17(2):53-68. PubMed ID: 4983581
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunologic examination in cases of death of the fetus due to hemolytic disease of the newborns].
    Kulich V; Pribilová A; Havránek E
    Cesk Gynekol; 1971 Apr; 36(3):136-9. PubMed ID: 4996773
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hematologic diagnosis of hemolytic disease of the newborn].
    Martín Villar J; Navarro Navarro JL
    Acta Obstet Ginecol Hisp Lusit; 1968; 16(4):285-93. PubMed ID: 4988904
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention of hemolytic disease of the newborn using anti-rhesus (D) gamma globulin].
    Borst-Eilers E
    Maandschr Kindergeneeskd; 1969 Dec; 37(7):243-51. PubMed ID: 4188422
    [No Abstract]   [Full Text] [Related]  

  • 15. [Attempt at Rhesus-prevention at the end of pregnancy].
    Baumgarten K; Reinold E; Koller A
    Wien Med Wochenschr; 1972 Sep; 122(39):551-2. PubMed ID: 4631515
    [No Abstract]   [Full Text] [Related]  

  • 16. [New possibilities of prognosis, therapy and prophylaxis of hemolytic disease of the newborn].
    Schreiner EW; Maroni E
    Praxis; 1968 Mar; 57(9):283-93. PubMed ID: 4975540
    [No Abstract]   [Full Text] [Related]  

  • 17. [Remote after-effects of hemolytic diseases in newborn, caused by the ABO- and Rh-incompatibility in the blood of mother and fetus].
    Nersisian VM
    Zh Eksp Klin Med; 1969; 9(5):82-5. PubMed ID: 4988140
    [No Abstract]   [Full Text] [Related]  

  • 18. Changing concepts in Rh isoimmunization.
    Goplerud CP
    J Iowa Med Soc; 1965 Apr; 55(4):187-9. PubMed ID: 4953693
    [No Abstract]   [Full Text] [Related]  

  • 19. [Investigations of conjugated bilirubinoids for the diagnosis of rhesus-incompatibility and clarification of fetal bilirubin metabolism].
    Kopecky P
    Z Geburtshilfe Perinatol; 1974 Oct; 178(5):349-59. PubMed ID: 4217504
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rh factor: anti-D isoimmunization and its therapeutic possibilities].
    Tucci G; Teofili MT
    Clin Ter; 1967 Dec; 43(6):567-89. PubMed ID: 4979582
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.